Sanofi (SNY) Reports Q4 EPS of EUR0.20

Sanofi (NASDAQ: SNY) reported Q4 EPS of EUR0.20. Revenue for the quarter came in at EUR8.99 billion versus the consensus estimate of EUR8.89 billion.

• Sanofi expects 2019 business EPS(1) to grow between 3% and 5%(7) at CER, barring unforeseen major adverse events. Applying average January 2019 exchange rates, the positive currency impact on 2019 business EPS is estimated to be between 1% to 2%.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Sanofi (SNY) call put ratio 8.4 calls to 1 put with a focus on July 45 calls